Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian P Wicks

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Arthritis and Rheumatism|October 7, 2005
Severely compromised quality of life in women and those of lower socioeconomic status waiting for joint replacement surgeryIlana N Ackerman, Stephen E Graves, Ian P Wicks, et al.
Seminars in Arthritis and Rheumatism|June 29, 2019
The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapyDaniel Boulos, Susanna M Proudman, Robert G Metcalf, et al.
Arthritis Research & Therapy|April 17, 2015
Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic diseaseSharon Van Doornum, Megan Bohensky, Mark A Tacey, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosisGene-Siew Ngian, Joanne Sahhar, Susanna M Proudman, et al.
Arthritis and Rheumatism|December 2, 2005
Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factorKate E Lawlor, Peter K K Wong, Ian K Campbell, et al.
Journal of Leukocyte Biology|July 2, 2011
Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritisKate E Lawlor, Scott D Smith, Annemarie van Nieuwenhuijze, et al.
The Medical Journal of Australia|June 15, 2018
Information in referrals to public outpatient specialist clinics for back pain: audit results and consensus recommendationsLauren Ross, Adam de Gruchy, Uyen M Phan, et al.
Molecular Immunology|August 13, 2013
GM-CSF as a therapeutic target in inflammatory diseasesAnnemarie van Nieuwenhuijze, Marije Koenders, Debbie Roeleveld, et al.
Rheumatology (Oxford, England)|September 5, 2015
Suppression of inflammatory disease activity in rheumatoid arthritis is associated with improvements in retinal microvascular healthJohn Hsing-Yih Moi, Lauren A B Hodgson, Ian P Wicks, et al.
Internal Medicine Journal|August 15, 2022
How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practiceJessica L Fairley, Mandana Nikpour, Heather G Mack, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Arthritis and Rheumatism|October 7, 2005
Severely compromised quality of life in women and those of lower socioeconomic status waiting for joint replacement surgeryIlana N Ackerman, Stephen E Graves, Ian P Wicks, et al.
Seminars in Arthritis and Rheumatism|June 29, 2019
The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapyDaniel Boulos, Susanna M Proudman, Robert G Metcalf, et al.
Arthritis Research & Therapy|April 17, 2015
Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic diseaseSharon Van Doornum, Megan Bohensky, Mark A Tacey, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosisGene-Siew Ngian, Joanne Sahhar, Susanna M Proudman, et al.
Arthritis and Rheumatism|December 2, 2005
Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factorKate E Lawlor, Peter K K Wong, Ian K Campbell, et al.
Journal of Leukocyte Biology|July 2, 2011
Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritisKate E Lawlor, Scott D Smith, Annemarie van Nieuwenhuijze, et al.
The Medical Journal of Australia|June 15, 2018
Information in referrals to public outpatient specialist clinics for back pain: audit results and consensus recommendationsLauren Ross, Adam de Gruchy, Uyen M Phan, et al.
Molecular Immunology|August 13, 2013
GM-CSF as a therapeutic target in inflammatory diseasesAnnemarie van Nieuwenhuijze, Marije Koenders, Debbie Roeleveld, et al.
Rheumatology (Oxford, England)|September 5, 2015
Suppression of inflammatory disease activity in rheumatoid arthritis is associated with improvements in retinal microvascular healthJohn Hsing-Yih Moi, Lauren A B Hodgson, Ian P Wicks, et al.
Internal Medicine Journal|August 15, 2022
How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practiceJessica L Fairley, Mandana Nikpour, Heather G Mack, et al.
Pageof 11